COELENTERAZIN-ANALOGA
European patent · EP3490991 · In force
Register entry
- Publication number
- EP3490991
- Application number
- EP17749304
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 27, 2017
- Published
- Jun 5, 2019
- Granted
- Jan 6, 2021
- Protection ends at the latest
- Jul 26, 2037
- Next annual fee due
- Jul 31, 2027
- IPC classes
- C07D 487/04 (2006.01)A61K 31/4985 (2006.01)C12Q 1/66 (2006.01)
- Priority
- US 201662367689 P 28.07.2016
- PCT application
- PCT/US2017/044150 27.07.2017
- PCT publication
- WO2018/022865 01.02.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.07.2026 → 31.07.2027
Published in Swissreg on 01.08.2026
- Aug 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.07.2025 → 31.07.2026
Published in Swissreg on 01.08.2025
- Aug 1, 2024
Change
Published in Swissreg on 01.08.2024
- Aug 1, 2023
Change
Published in Swissreg on 01.08.2023
- Aug 8, 2022
Change
Published in Swissreg on 08.08.2022
- Nov 17, 2021
Change
Published in Swissreg on 17.11.2021
- Jan 27, 2021
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich
Published in Swissreg on 27.01.2021
- Jan 6, 2021
Granted
Published in Swissreg on 06.01.2021
Parties
Inventor
Atascadero CA 93422, US
San Luis Obispo CA 93405, US
Waunakee WI 53597, US
Madison WI 53505, US
Grover Beach CA 93433, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.